Skip to content

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05119153
Enrollment
19
Registered
2021-11-12
Start date
2019-11-05
Completion date
2021-10-31
Last updated
2021-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperglycemia

Keywords

coffee, glucose challenge, blood glucose levels

Brief summary

The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.

Detailed description

This is a single-blinded, randomized partial block design conducted over 6 weeks in two parts. In part 1 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a beverage containing 50 g of glucose. In part 2 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a standardized breakfast (corn flakes cereal + skim milk) containing 50 g of glucose. In each part, fasting and postprandial glucose profiles were determined.

Interventions

DIETARY_SUPPLEMENTMedium Roasted Coffee

12 oz medium roast coffee

DIETARY_SUPPLEMENTDark Roasted Coffee

12 oz dark roast coffee

DIETARY_SUPPLEMENTPlacebo Comparator

Placebo designed to mimic coffee color.

DIETARY_SUPPLEMENTLight Roasted Coffee

12 oz light roast coffee

Sponsors

North Carolina State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Subjects provided placebo and coffee beverages in a color coded bottles

Intervention model description

Randomized, single-blinded, partial block, crossover design

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

• Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

Exclusion criteria

* Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl. * Weight less than 110 pounds (55 kg) * Pre-existing health conditions, such as: * High cholesterol * Hypertension * Cardiovascular disease * Gastrointestinal motility disorders * Hypo- or hyperthyroidism * Anemia * Renal disease * Liver disease, including hepatitis B or C, cholestasis, cirrhotic liver disease, or non-alcoholic fatty liver disease * Chronic or acute pancreatitis * Diabetes type 1 or 2 * Insulin resistance * Polycystic ovary syndrome * Food allergies or intolerances to coffee/caffeine/dairy/corn-based cereals. * Currently taking prescription medication * Current smoker * Consumes more than 3 alcoholic beverages per day * Pregnant or breastfeeding * Not willing to take their own blood samples with finger sticks

Design outcomes

Primary

MeasureTime frameDescription
Changes in Blood Glucose6 weeksEach week, fasted baseline and postprandial measurements taken out to 240 minutes

Secondary

MeasureTime frameDescription
Changes in Glucose Area Under the Curve6 weeksUsed glucose changes over 240 minutes to construct area under the curve

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026